Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GMAB | BNTX |
|---|---|---|
| Price | $34.87 | $97.26 |
| Change today | ▼ 2.26% | ▼ 1.06% |
| Market cap | $21.76B | $24.43B |
| Return, 3 months | +26.2% | +3.6% |
| Return, year to date | +13.2% | +2.2% |
| Return, 1 year | +9.8% | -4.8% |
| P/E (TTM) | 27.6 | -12.8 |
| P/B | 3.7 | 1.2 |
| P/E percentile vs own 5y | 49th | 41st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +24.9% | -59.5% |
| Net profit growth (YoY) | -9.8% | -112.3% |
| Gross margin | 93.0% | 75.5% |
| Operating margin | 32.3% | -46.4% |
| Net margin | 19.1% | -63.6% |
| Return on equity | 14.0% | -9.3% |
| Analyst target vs. price | +14.7% | +30.4% |
| Analyst buy share | 89% | 79% |
| RSI (14) | 68 | 48 |
| 30-day volatility | 28.5% | 71.8% |
| Max drawdown, 1 year | -32.5% | -29.7% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
